ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2,3,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
5,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
5,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
5,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
5,5,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
6,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
6,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
6,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
6,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
7,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
7,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
8,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
8,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
9,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
10,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
10,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
10,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
10,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
11,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
11,4,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
12,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
14,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
15,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
15,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
15,4,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
16,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
17,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
17,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
18,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
18,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
18,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
20,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
21,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
22,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
22,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
23,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
23,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
24,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
24,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
25,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
25,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
26,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
26,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
27,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
28,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
28,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
29,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
29,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
30,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
31,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
32,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
33,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
34,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
35,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
37,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
38,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
39,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
40,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
41,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
42,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
43,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
44,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
45,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
46,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
47,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
49,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
50,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
51,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
52,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
53,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
54,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
55,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
56,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
56,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
57,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
58,1,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
59,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
59,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
59,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
59,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
60,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
61,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
61,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
61,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
62,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
62,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
62,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
62,4,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
62,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
62,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
63,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
64,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
65,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
66,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
67,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
67,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
68,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
69,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
70,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
71,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
72,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
72,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
72,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
73,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
73,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
74,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
74,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
75,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
75,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
75,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
75,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
76,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
76,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
78,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
78,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
78,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
79,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
81,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
82,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
83,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
83,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
84,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
84,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
87,1,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
87,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
88,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,2,Sarcomatoid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
89,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
89,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
89,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
90,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
91,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
91,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
92,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
92,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
93,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
94,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
95,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
95,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
95,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
95,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
95,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
95,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
96,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
97,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
98,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
98,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
99,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
99,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
100,1,Adenocarcinoma metastatic,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
100,2,Sarcomatoid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,1,Dreamy state,Partial complex seizures,Seizures (incl subtypes),Nerv,N
102,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
102,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
103,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
103,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
104,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
104,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
105,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
105,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
105,3,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
105,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
105,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
106,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
106,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
106,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
108,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
110,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
110,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
110,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
112,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
113,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
113,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
115,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
115,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
116,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
117,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
117,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
118,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
118,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
119,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
120,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
120,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
121,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
121,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
121,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
121,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
122,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
122,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
122,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
123,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
124,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
124,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
124,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
124,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
125,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
126,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
126,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
126,4,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
126,5,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
126,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
127,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
127,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
127,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
128,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
128,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
128,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
128,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
129,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
129,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
129,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
129,4,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
129,5,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
129,6,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
129,7,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
130,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
130,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
130,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
130,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
131,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
131,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
131,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
131,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
131,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
131,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
131,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
131,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
131,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
133,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
133,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
134,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
135,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
135,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
135,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
136,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
136,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
136,3,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
136,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
136,5,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
137,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
137,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
137,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
137,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
137,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
137,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
137,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
137,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
138,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
139,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
140,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
140,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
140,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
140,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
141,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
142,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
142,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
143,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
144,1,Cardiorenal syndrome,Heart failures NEC,Heart failures,Card,N
144,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
144,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
144,4,Respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
145,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
145,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
146,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
147,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
147,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
147,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
147,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
147,6,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
147,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
147,8,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
148,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
148,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
149,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
150,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
151,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
151,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
152,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
152,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
153,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
153,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
153,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
153,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
154,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
155,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
157,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
158,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
160,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
160,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
160,3,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
160,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
161,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
161,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
161,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
161,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
161,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
162,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,3,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
163,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
163,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
163,6,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
163,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
164,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
165,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
165,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
165,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
165,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
165,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
166,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
166,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
166,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
167,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
167,2,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
167,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
167,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
167,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
167,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
167,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
168,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
168,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
169,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
169,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
169,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
169,4,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
169,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
170,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
170,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
170,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
170,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
170,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
170,7,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
170,8,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
171,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
171,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
171,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
171,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
172,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
172,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
173,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
174,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,2,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
176,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
177,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
178,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
178,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
179,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
179,2,Primary mediastinal large B-cell lymphoma recurrent,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
180,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
181,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
181,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
181,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
182,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
182,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
182,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
182,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
182,6,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
182,7,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
182,8,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
182,9,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,Y
182,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
183,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
184,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
184,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
185,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
186,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
186,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
186,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
186,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
187,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
188,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
189,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
190,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
191,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
191,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
192,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
192,2,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
192,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
192,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
192,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
192,6,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
192,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
192,8,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
192,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
192,10,Headache,Headaches NEC,Headaches,Nerv,N
192,11,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
192,12,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
192,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
192,14,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
192,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,17,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
192,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
192,19,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
192,20,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
193,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
193,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
194,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
194,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
195,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
196,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
197,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
198,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
198,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
199,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
199,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
200,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
200,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
201,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
202,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
202,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
204,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
206,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
207,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
207,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
207,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
207,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
207,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
207,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
207,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
208,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
209,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
209,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
210,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
211,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
212,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
212,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
213,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
214,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
214,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
215,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
216,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
216,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
216,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
216,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
220,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
221,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
222,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
223,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
224,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
224,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
225,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
226,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
227,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
227,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
228,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
228,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
229,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
229,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
230,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
230,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
231,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
231,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
232,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
233,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
234,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
235,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
236,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
238,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
238,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
239,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
239,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
240,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
240,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
241,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
241,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
242,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
242,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
243,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
243,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
244,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
244,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
245,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
245,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
246,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
246,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
247,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
247,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
248,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
248,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
249,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
249,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
250,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
250,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
251,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
251,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
252,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
252,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
253,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
254,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
255,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
256,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
256,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
257,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
257,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
258,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
259,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
260,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
261,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
262,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
263,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
264,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
265,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
265,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
266,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
267,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
267,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
267,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
268,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
269,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
269,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
269,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
269,4,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
270,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
270,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
271,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
271,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
272,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
272,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
272,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
273,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
273,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
273,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
274,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
274,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
275,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
276,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
276,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
277,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
277,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
277,3,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
277,4,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
277,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
278,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
279,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
281,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
281,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
282,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
282,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
283,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
283,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
283,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
284,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
286,1,Hepatitis B core antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
287,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
288,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
289,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
289,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
290,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
291,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
291,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
292,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
292,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
293,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
293,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
294,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
294,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
295,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
295,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
295,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
297,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
298,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
299,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
300,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
300,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
301,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
302,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
302,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
302,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
302,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
302,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
302,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
303,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
303,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
303,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
304,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
305,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
306,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
306,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
307,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
308,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
308,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
308,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
309,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
309,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
310,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
311,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
312,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
313,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
314,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
314,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
315,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
315,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
316,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
316,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
316,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
318,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,Y
318,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
319,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
319,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
320,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
321,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
322,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
323,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
324,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
325,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
326,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
327,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
328,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
329,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
330,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
331,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
332,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
333,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
334,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
335,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
336,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
337,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
338,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
339,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
340,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
341,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
342,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
343,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
344,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
345,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
346,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
347,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
348,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
349,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
350,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
351,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
352,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
353,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
354,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
355,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
356,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
357,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
358,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
359,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
360,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
361,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
362,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
363,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
364,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
365,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
366,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
367,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
368,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
369,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
370,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
371,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
372,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
373,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
374,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
375,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
376,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
377,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
378,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
379,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
380,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
381,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
382,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
383,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
384,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
385,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
386,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
387,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
388,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
389,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
390,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
391,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
392,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
393,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
394,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
395,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
396,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
397,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
398,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
399,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
400,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
401,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
402,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
403,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
404,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
405,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
406,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
407,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
408,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
409,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
410,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
411,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
412,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
413,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
413,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
414,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
415,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
416,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
417,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
419,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
420,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
421,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
422,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
423,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
424,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
425,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
426,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
427,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
428,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
429,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
430,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
432,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
433,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
434,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
435,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
436,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
437,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
438,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
439,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
440,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
441,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
442,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
443,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
444,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
445,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
446,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
447,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
451,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
452,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
453,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
455,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
456,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
456,2,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
456,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
456,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
456,5,Muscle strength abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
456,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
456,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
456,8,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
457,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
457,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
458,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
458,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
458,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
459,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
459,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
461,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
462,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
463,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
463,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
464,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
464,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
464,3,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
465,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
